spending on DTC decreasing | Arthritis Information
According to this, spending on Direct To Consumer drug marketing is decreasing:
http://trusted.md/feed/items/system/2008/05/23/professional_advertising_doing_well_dtc_not_so_much
An excerpt from the article in the above link:
"...pharma spending on physician marketing is alive and well and probably growing.
Spending on direct-to-consumer (DTC) advertising, on the other hand, is DECREASING.
The recent May issue of MedAdNews lays out the facts in its 14th Annual Report on DTC: .37 billion was spent on DTC in 2007 vs. .61 in 2006 (a 4.2% decrease)."
.37 billion still in my opinion is too much, also the decrease could be due to no new "blockbuster" drugs to promote that year and several big name drugs going off patent, hence no more dtca for them.
The article also has a link to story that DTC Rozerem ads cost more than the drug made in profit....
And a link to the agenda for meeting about more ways to market to physicians. Lots of percentages on the number of patients outside a med's target that they should be able to get it rx'd to.
Copyright ArthritisInsight.com